Weekly round-up #240
VALIDATE Winter Seminar: A flexible and efficient platform to develop a nanovaccine against Burkholderia pseudomallei
We are very excited to announce our next VALIDATE Seminar, this time talking about nanovaccines for melioidosis! In "A flexible and efficient platform to develop a nanovaccine against Burkholderia pseudomallei", Dr Alfredo Torres will discuss his Lab's work at UTMB which uses gold nanoparticles for the delivery of multicomponent antigens, identified by the bio-immunoinformatic analysis, that is able to induce vaccine-mediated immunity, promoting protection against melioidosis disease.
This seminar is open to all, so spread the word and register today - www.validate-network.org/event/seminar-nanovaccine-burkholderia
- UK-US Research: Ecology and Evolution of Infectious Diseases 2022 - The funders wish to encourage high quality, innovative research on the ecological, evolutionary, and social drivers that influence the transmission dynamics of infectious diseases - deadline: 16 November 2022
- MRC New Unit Funding Opportunity - Apply for MRC new unit funding to tackle complex and interdisciplinary health challenges. - deadline 23 February 2024
- BSI public engagement funding - Provides financial support to help BSI members develop and deliver activities to engage with the public in all formats. - deadline 1 February 2022 and 1 June 2023
- MRC New Unit Funding Opportunity - Apply for MRC new unit funding to tackle complex and interdisciplinary health challenges -deadline 23 February 2024
You can find a list of all relevant external funding we've spotted for our members on our external funding page.
Training Opportunities and Events:
- International Conference on Vaccine Production and Designs 2022, London, UK, 14- 15 November 2022
- Global Health Network Conference 2022, Cape Town, South Africa, 24 - 25 November 2022
- British Society for Immunology Congress 2022, Liverpool, United Kingdom, 5 December 2022
- International Conference on Clinical Immunology and Immunotoxicology 2023 (New York), New York, USA, 28 - 29 January 2023
- International Conference on Clinical Immunology and Immunotoxicology 2023 (London), London, UK, 16 - 17 March 2023
- Research Associate in Immunology, The Hull York Medical School, University of York, UK, deadline 26 October 2022
Other relevant career opportunities are on our jobs page.
- Review: Narrative review on century of respiratory pandemics from Spanish flu to COVID‑19 and impact of nanotechnology on COVID‑19 diagnosis and immune system boosting, Elkhatib FE et al, in Viroogy Journal
- Mycobacterium tuberculosis exploits MPT64 to generate myeloid-derived suppressor cells to evade the immune system, Singh S et al, in Cellular and Molecular Life Sciences
- Heterologous prime-boost BCG with DNA vaccine expressing fusion antigens Rv2299c and Ag85A improves protective efficacy against Mycobacterium tuberculosis in mice, Wu J et al, in Frontiers in Microbiology
- Structural analysis of PpSP15 and PsSP9 sand fly salivary proteins designed with a self-cleavable linker as a live vaccine candidate against cutaneous leishmaniasis, Lajevardi MS et al, in parasites and vectors
Check out our Publications Page for members' publications and email VALIDATE@ndm.ox.ac.uk if you have a paper you would like us to include.
Highlights on Twitter this week:
Nature Careers asked if recent negative publicity is putting people off academia, TB is once again the biggest global pathogen killer (also reported by TB News Daily), and Dr Melvin Sanicas tweeted a guide for countering science misinformation. Nature Careers released a special edition on Racism in Science, published a roadmap to improve the lives of you researchers, and discussed how to engage acquaintances to advance in your career. Hugh Kearns had some advice for researchers nervous about giving presentation and Science.org reported on the historic drop in STEM PhD graduations after COVID. Research Whisper had released a handy tool for assessing research Impact and Texas Biomed has received $3.5 million to establish a TB vaccine research programme. Keep up to date with all the relevant news and opportunities by following @NetworkVALIDATE on Twitter.
Published: 26 October 2022
